Julia F Slejko
Overview
Explore the profile of Julia F Slejko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kardas P, Bennett B, Borah B, Burnier M, Daly C, Hiligsmann M, et al.
Front Pharmacol
. 2025 Jan;
15:1444012.
PMID: 39764461
Background: Non-adherence to medication remains a persistent and significant challenge, with profound implications for patient outcomes and the long-term sustainability of healthcare systems. Two decades ago, the World Health Organization...
2.
Pan Y, Devabhakthuni S, Cooke C, Slejko J
Drugs Real World Outcomes
. 2024 Dec;
12(1):75-81.
PMID: 39708226
Background And Objective: Performing lipid testing after statin initiation is recommended to monitor response. Inadequate response may indicate non-adherence, which is associated with an increased risk of cardiovascular events and...
3.
Tran P, dosReis S, Onukwugha E, Lee H, Slejko J
J Manag Care Spec Pharm
. 2024 Nov;
30(12):1455-1466.
PMID: 39612255
Background: Individuals with depression who do not respond to initial antidepressant may switch to a different antidepressant, add a second antidepressant, or add an atypical antipsychotic. Previous studies comparing these...
4.
Rizk J, Slejko J, Heil E, Seo D, Qato D
BMJ Open Qual
. 2024 Jul;
13(3.
PMID: 39053916
Background: The US Food and Drug Administration (FDA) issued a warning in December 2018 regarding an increased risk of aortic aneurysms and aortic dissections associated with fluoroquinolone (FQ) use. This...
5.
Slejko J, Mattingly 2nd T, Wilson A, Xie R, Chapman R, Amill-Rosario A, et al.
Value Health
. 2024 Jun;
28(3):399-405.
PMID: 38852668
Objectives: Prior work identified 6 key value elements (attributes of treatment and desired outcomes) for individuals living with major depressive disorder (MDD) in managing their condition: mode of treatment, time...
6.
Poudel N, Ricci S, Slejko J
J Manag Care Spec Pharm
. 2023 Dec;
30(3):234-240.
PMID: 38088898
The Inflation Reduction Act passed in August 2022 empowers the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum fair prices for certain expensive drugs. In the process of...
7.
Carlisle K, Brown J, Kim J, Turner D, Slejko J, Kuo J, et al.
Surgery
. 2023 Oct;
175(1):153-160.
PMID: 37872047
Background: Papillary thyroid microcarcinomas may be treated with radiofrequency ablation, active surveillance, or surgery. The objective of this study was to use mathematical modeling to compare treatment alternatives for papillary...
8.
Hayssen H, Sahoo S, Nguyen P, Mayorga-Carlin M, Siddiqui T, Englum B, et al.
J Vasc Surg Venous Lymphat Disord
. 2023 Oct;
12(2):101693.
PMID: 37838307
Objective: Venous thromboembolism (VTE) is a preventable complication of hospitalization. Risk-stratification is the cornerstone of prevention. The Caprini and Padua are two of the most commonly used risk-assessment models (RAMs)...
9.
Zhang C, Zafari Z, Slejko J, Camelo Castillo W, Reeves G, dosReis S
Front Psychiatry
. 2023 Jun;
14:1127852.
PMID: 37333921
Introduction: Despite considerable investment in suicide prevention since 2001, there is limited evidence for the effect of suicide prevention interventions among children and adolescents. This study aimed to estimate the...
10.
Kim J, Roth E, Carlisle K, Munir K, Fletke K, Slejko J, et al.
Endocr Pract
. 2023 Apr;
29(7):525-528.
PMID: 37121401
Objective: While surgical resection has been the traditional standard treatment for small (≤1 cm), differentiated thyroid cancers, active surveillance (AS) and radiofrequency ablation (RFA) are increasingly considered. The aim of...